Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript
|
Abraxis BioScience, Inc. (ABII)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/29/2010 |
BW
| Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand |
07/23/2010 |
BW
| ABRAXANE® Approved for Marketing in Japan for Breast Cancer |
07/19/2010 |
BW
| Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc. |
07/12/2010 |
BW
| Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII |
07/07/2010 |
BW
| The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII |
07/02/2010 |
BW
| Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition |
06/30/2010 |
BW
| Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc. |
06/30/2010 |
BW
| Robbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene Corporation |
06/30/2010 |
BW
| Finkelstein Thompson LLP Announces Investigation of Abraxis Bioscience Inc. |
06/30/2010 |
BW
| Ryan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc. |
06/30/2010 |
BW
| Kendall Law Group Investigates Abraxis BioScience Inc. Merger for Shareholders |
06/30/2010 |
BW
| Rigrodsky & Long, P.A. Investigates Abraxis BioScience Inc. Buyout |
06/30/2010 |
BW
| Bernstein Liebhard LLP Announces Investigation of Acquisition of Abraxis BioScience Inc. by Celgene Corp. |
05/18/2010 |
BW
| Over 30 Scientific Presentations at ASCO Exploring ABRAXANE's Expanded Potential in Multiple Difficult-to-Treat Cancers |
05/14/2010 |
BW
| Saint John??s Trustee & Abraxis Founder Patrick Soon-Shiong, M.D. Receives Distinguished Medical Science Award from the Friends of the National Library of Medicine |
05/06/2010 |
BW
| Abraxis BioScience Reports First Quarter 2010 Financial Results |
04/20/2010 |
BW
| ABRAXANE® in Combination with Bevacizumab Shows Promise in New Model of Triple Negative Breast Cancer |
04/13/2010 |
BW
| Abraxis Founder & Executive Chairman to Present at 7th Annual World Health Care Congress |
04/13/2010 |
BW
| Scottish Medicines Consortium Accepts ABRAXANE® for Use within National Health Service for Scotland |
04/08/2010 |
BW
| Abraxis to Present Phase I/II Pancreatic Survival Data at 101st Annual Meeting of the American Association for Cancer Research |
03/17/2010 |
BW
| ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer |
03/11/2010 |
BW
| Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results |
03/03/2010 |
BW
| Sanjay Gupta, Abraxis Senior Vice President and Advisor to the Executive Chairman, Named Young Global Leader by the World Economic Forum |
02/24/2010 |
BW
| Abraxis BioScience Announces Date for 2009 Fourth Quarter Financial Results and Investor Conference Call |
|
|